Genenta Science Spa Stock Analysis
GNTA Stock | USD 3.90 0.09 2.26% |
Genenta Science SpA is undervalued with Real Value of 8.12 and Target Price of 21.32. The main objective of Genenta Science stock analysis is to determine its intrinsic value, which is an estimate of what Genenta Science SpA is worth, separate from its market price. There are two main types of Genenta Science's stock analysis: fundamental analysis and technical analysis.
The Genenta Science stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Genenta Science's ongoing operational relationships across important fundamental and technical indicators.
Genenta |
Genenta Stock Analysis Notes
About 39.0% of the company shares are held by company insiders. The book value of Genenta Science was currently reported as 0.92. The company recorded a loss per share of 0.51. Genenta Science SpA had not issued any dividends in recent years. Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company was incorporated in 2014 and is headquartered in Milan, Italy. Genenta Science is traded on NASDAQ Exchange in the United States. To learn more about Genenta Science SpA call the company at 39 02 26 43 46 81 or check out https://www.genenta.com.Genenta Science SpA Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Genenta Science's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Genenta Science SpA or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Genenta Science SpA generated a negative expected return over the last 90 days | |
Genenta Science SpA has high historical volatility and very poor performance | |
Genenta Science SpA has high likelihood to experience some financial distress in the next 2 years | |
Net Loss for the year was (11.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
Genenta Science SpA currently holds about 37.24 M in cash with (11.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.04. | |
Roughly 39.0% of the company shares are held by company insiders | |
Latest headline from news.google.com: Is Genenta Science S.p.A. the Best Italian Stock to Buy in 2025 - Yahoo Finance UK |
Genenta Science SpA Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Genenta Science previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
24th of April 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
24th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Genenta Science Environmental, Social, and Governance (ESG) Scores
Genenta Science's ESG score is a quantitative measure that evaluates Genenta Science's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Genenta Science's operations that may have significant financial implications and affect Genenta Science's stock price as well as guide investors towards more socially responsible investments.
Genenta Stock Institutional Investors
Shares | Alti Global Inc | 2024-12-31 | 200.3 K | Algebris Investment Management (uk) Llp | 2024-12-31 | 45 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | Ubs Group Ag | 2024-12-31 | 0.0 |
Genenta Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 71.33 M.Genenta Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.60) | (0.57) | |
Return On Capital Employed | (0.65) | (0.69) | |
Return On Assets | (0.60) | (0.57) | |
Return On Equity | (0.66) | (0.62) |
Management Efficiency
Genenta Science SpA has return on total asset (ROA) of (0.2583) % which means that it has lost $0.2583 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4289) %, meaning that it created substantial loss on money invested by shareholders. Genenta Science's management efficiency ratios could be used to measure how well Genenta Science manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.57. In addition to that, Return On Capital Employed is expected to decline to -0.69. At present, Genenta Science's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 1.3 M, whereas Net Tangible Assets are forecasted to decline to about 13.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.01 | 1.10 | |
Tangible Asset Value | 28 M | 24.9 M | |
Tangible Book Value Per Share | 1.01 | 1.10 | |
Enterprise Value Over EBITDA | (6.00) | (6.30) | |
Price Book Value Ratio | 4.59 | 6.97 | |
Enterprise Value Multiple | (6.00) | (6.30) | |
Price Fair Value | 4.59 | 6.97 | |
Enterprise Value | 89.6 M | 128.7 M |
Understanding the operational decisions made by Genenta Science management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Technical Drivers
As of the 2nd of March, Genenta Science retains the Standard Deviation of 4.67, market risk adjusted performance of (0.39), and Risk Adjusted Performance of (0.02). Genenta Science technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Genenta Science SpA Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Genenta Science middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Genenta Science SpA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Genenta Science SpA Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Genenta Science insiders, such as employees or executives, is commonly permitted as long as it does not rely on Genenta Science's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Genenta Science insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rosenwald Lindsay A Md over two months ago Disposition of 506245 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 | ||
Driscoll Martin J over two months ago Acquisition by Driscoll Martin J of 4999 shares of Genenta Science at 0.25 subject to Rule 16b-3 | ||
Rosenwald Lindsay A Md over six months ago Disposition of 64562 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 | ||
Rosenwald Lindsay A Md over six months ago Disposition of 2287 shares by Rosenwald Lindsay A Md of Genenta Science subject to Rule 16b-3 |
Genenta Science Outstanding Bonds
Genenta Science issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Genenta Science SpA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Genenta bonds can be classified according to their maturity, which is the date when Genenta Science SpA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
MGM Resorts International Corp BondUS552953CD18 | View |
Genenta Science Predictive Daily Indicators
Genenta Science intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Genenta Science stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Genenta Science Corporate Filings
10th of February 2025 Other Reports | ViewVerify | |
6K | 30th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
20th of December 2024 Other Reports | ViewVerify | |
6K | 13th of December 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 14th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
6K | 29th of October 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Genenta Science Forecast Models
Genenta Science's time-series forecasting models are one of many Genenta Science's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Genenta Science's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Genenta Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Genenta Science prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Genenta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Genenta Science. By using and applying Genenta Stock analysis, traders can create a robust methodology for identifying Genenta entry and exit points for their positions.
Last Reported | Projected for Next Year |
Current Genenta Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Genenta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Genenta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
21.32 | Buy | 2 | Odds |
Most Genenta analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Genenta stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Genenta Science SpA, talking to its executives and customers, or listening to Genenta conference calls.
Genenta Stock Analysis Indicators
Genenta Science SpA stock analysis indicators help investors evaluate how Genenta Science stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Genenta Science shares will generate the highest return on investment. By understating and applying Genenta Science stock analysis, traders can identify Genenta Science position entry and exit signals to maximize returns.
Begin Period Cash Flow | 29.8 M | |
Total Stockholder Equity | 20.4 M | |
Property Plant And Equipment Net | 57 K | |
Cash And Short Term Investments | 18.8 M | |
Net Invested Capital | 20.4 M | |
Shares Float | 11.2 M | |
Cash | 3.7 M | |
200 Day M A | 4.241 | |
50 Day M A | 4.2717 | |
Net Interest Income | 309.3 K | |
Total Current Liabilities | 1.7 M | |
Investments | -14.9 M | |
Stock Based Compensation | 739.9 K | |
Common Stock Shares Outstanding | 18.2 M | |
Free Cash Flow | -11.2 M | |
Operating Income | -11.7 M | |
Other Current Assets | 2.5 M | |
Accounts Payable | 295 K | |
Net Debt | -3.7 M | |
Depreciation | 42.5 K | |
Other Operating Expenses | 11.7 M | |
Non Current Assets Total | 1.1 M | |
Total Current Assets | 21.3 M | |
Liabilities And Stockholders Equity | 22.3 M | |
Home Category | ADR | |
Non Currrent Assets Other | 980.7 K |
Complementary Tools for Genenta Stock analysis
When running Genenta Science's price analysis, check to measure Genenta Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genenta Science is operating at the current time. Most of Genenta Science's value examination focuses on studying past and present price action to predict the probability of Genenta Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genenta Science's price. Additionally, you may evaluate how the addition of Genenta Science to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Money Managers Screen money managers from public funds and ETFs managed around the world |